Found: 1
Select item for more details and to access through your institution.
Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1479, doi. 10.1111/dom.15448
- By:
- Publication type:
- Article